[Editor's Note: The Dr. Henry Niman-style propaganda about Bird Flu resistance presented below by Patricia Doyle, PhD is not what's "disturbing" (to quote her). What's "distrubing" is that Patricia Doyle, PhD is presenting the information. I haven't followed Patricia Doyle's writings or radio interviews on a regular basis, but over the years, I've read her essays and heard her interviews occasionally with Jeff Rense and viewed her as an ally of mankind in exposing the lies and deceit of the US government when it comes to laboratory-created "emerging diseases". But to now read Patricia Doyle's uncritical endorsement of the utter tripe and lies promoted by three of the biggest fear-promoting propagandists working for the government: Dr.
Jeffrey Taubenberger (who was THOROUGHLY outed by Dr A True Ott last year as the CIA's designated point man who went up to Alaska in 1997 and dug up the bodies of locals who died of the 1918 Spanish flu virus so that he, and his CIA pals at Fort Detrick, MD could re-create an even deadlier killer pathogen), Matthew J Memoli, MD, and the NIH and National Cancer Institute's TOP propaganda mouth piece and disinformation peddler of the century, Dr Anthony Fauci, as if these guys were honest scientists, rather than the lying jackals they actually are, is more than I can bear.
It also concerns me that Patricia refers to www.physorg.com as her source for her article posted on March 27, 2010 at rense.com.
Do a little digging, and you find that physorg.com is just a wee bit more connected and funded than you would expect from a web site founded in 2004 "by two PhD students motivated by the void in hard science news designed for informed and educated readers" The web site was bought out in 2005 by Omicron Technology Limited which has a relatively modest size building on Peel Road in Douglas, Isle Of Man (UK), and a much larger buiding in London at 37 Warren Street, Westminster. A google search turned up very little information about this company, except to find that onicron is the 15th letter of the Greek alphabet
This organization/company merits deeper investigation. Perhaps some enterprising person out there with the time and expertise can provide more information on the size of this organization and who runs it....Ken Adachi]
From Keith Howe <firstname.lastname@example.org>
March 28, 2010
Subject: Birds of a feather Promote Flu Terror together
Date: Sun, March 28, 2010
To: Ken Adachi
Looks like Henry Niman has a new friend spreading Flu Terror, Patricia Doyle. In her
following article she states;
“Swine Flu Over? Guess Again - And The News Gets Worse”
From Patricia Doyle, PhD 3-27-10
“Both patients in the new report developed resistance to the key influenza drug
oseltamivir (Tamiflu), and one also demonstrated clinical resistance to another
antiviral agent, now in experimental testing, intravenous peramivir, note senior
authors Matthew J Memoli, MD, and Jeffery K Taubenberger, MD, PhD.”
This is not a development of resistance to these drugs, they were practically
useless, and in some cases deadly, from the beginning! More pharmaceutical fraud!
As far as Jeffrey Taubenberger goes, here is a little “cull the population” diddy on
him! (along with Fauci and Julie Gerberding, all of whom should be sent to the
”But Dr. Jeffery Taubenberger, chief of the molecular pathology department at
the Armed Forces Institute of Pathology in Washington, had an idea for finding that
ancient virus. He recalled that his institute had a warehouse of autopsy tissue,
established by President Lincoln.
Dr. Taubenberger investigated and found tissue from two soldiers who died of the
1918 flu, one in Massachusetts, one on Long Island. The tissue was snips of lung
soaked in formalin and encased in little blocks of wax. In that tissue was the
virus, broken and degraded, but there, untouched for nearly 80 years.
Then Dr. Taubenberger received a third sample, from a woman who had died in
Brevig, Alaska, when the flu swept through her village, killing 72 adults and
leaving just five. The dead were buried in a mass grave in the permafrost. A retired
pathologist, Johan Hultin, hearing of Dr. Taubenberger's quest, had traveled from
his home in San Francisco at his own expense. He dug up the grave with the
villagers' permission, extracted the woman's still frozen lung tissue and sent it to
Dr. Taubenberger and his colleagues spent nearly a decade carefully extracting
and piecing together the viral genes, like putting together a jigsaw puzzle. Along
the way, they published findings that they and others used to try to understand the
1918 flu, but until now they had published only the sequences of five of the eight
genes that make up the virus. The last three, which make up half of the virus's
length, are published today in their paper in Nature.”
see full story at:
"Man Made Swine Flu Designed to Cause Genocide Native Alaskan verifies how 1918 killer virus was duplicated"
By Greg Szymanski, JD Aug. 16, 2009
"I am become death, the destroyer of worlds" Robert Oppenheimer, Trinity 1945 . Dr.
Jeffrey Taubenberger, hired by the UN and U.S. government, reversed engineered the 1918 flu virus that killed upwards of 50 million. http://www.arcticbeacon.com/greg/?p=1244
If idiots like this would leave the human immune system alone, and quit resurrecting
and making stronger, more resistant viruses in their labs (including human petri
dishes) the flu would be nothing more than a 10 day inconvenience! Of course that
would not fit their "agenda" nor be profitable to them now, would it?
Swine Flu Over? Guess Again -
And The News Gets Worse
From Patricia Doyle, PhD
Hello Jeff - Most people haven't a clue if they get their news from network talking head droids. There is a very disturbing situation that has begun - now H1N1 is resistant to the new antiviral in clinical trials.
Giving antivirals to immune compromised individuals is, in my opinion, risky because their immune systems don't work properly.
Source: PHYSORG.com News
Rapid development of drug-resistant 2009 H1N1 influenza reported in 2 cases
Doctors from the National Institute of Allergy and Infectious Diseases (NIAID) report that 2 people with compromised immune systems who became ill with [pandemic (H1N1) 2009] influenza [virus infection] developed drug-resistant strains of virus after less than 2 weeks on therapy. Doctors who treat prolonged influenza infection should be aware that even a short course of antiviral treatment may lead to drug-resistant virus, say the authors, and clinicians should consider this possibility as they develop initial treatment strategies for their patients who have impaired immune function.
Both patients in the new report developed resistance to the key influenza drug oseltamivir (Tamiflu), and one also demonstrated clinical resistance to another antiviral agent, now in experimental testing, intravenous peramivir, note senior authors Matthew J Memoli, MD, and Jeffery K Taubenberger, MD, PhD. This is the 1st reported case of clinically significant peramivir-resistant 2009 H1N1 illness, say the scientists. The report is scheduled to appear in print on 1 May  in Clinical Infectious Diseases and is now online [MJ Memoli et al: Rapid selection of oseltamivir and peramivir resistant pandemic H1N1 during therapy in 2 immunocompromised hosts. Clinical Infectious Diseases DOI:10. 1086/651605 (2010)]. The people in the current case report had immune limitations due to blood stem cell transplants that occurred several years previously. Both recovered from their influenza infections.
"While the emergence of drug-resistant influenza virus is not in itself surprising, these cases demonstrate that resistant strains can emerge after only a brief period of drug therapy," says NIAID Director Anthony S Fauci, MD. "We have a limited number of drugs available for treating influenza and these findings provide additional urgency to efforts to develop antivirals that attack influenza virus in novel ways."
The pandemic (H1N1) 2009 influenza virus is susceptible to just one of the 2 available classes of anti-influenza drugs, the neuraminidase inhibitors. Besides oseltamivir, other neuraminidase inhibitors are zanamivir (Relenza), which is inhaled, and the intravenously administered investigational drug peramivir. As the H1N1 influenza pandemic unfolded, laboratory tests of virus strains isolated from patients showed that some strains contained a genetic mutation (the H275Y mutation) that makes the virus less susceptible to some neuraminidase inhibitors.
The 2 people in the current case study had pre-existing medical conditions that impaired their immune system function before contracting 2009 H1N1 flu. Strains of pandemic (H1N1) 2009 virus containing the H275Y mutation had been reported previously in people with diminished immune function, but in previous cases the mutation arose after more than 24 days of continuous therapy. In the newly described cases, the mutation appeared after 14 days in one individual and after 9 days in the 2nd. "Although the recommended length of treatment with oseltamivir is 5 days, it is common for physicians to continue giving this 1st-line drug longer if the patient does not improve," says Dr Memoli.
Both people in the current report received oseltamivir for extended periods but they continued to shed virus in their nasal secretions throughout treatment. When one patient's condition worsened despite 24 days of oseltamivir treatment, doctors administered peramivir for 10 days. The drug did not reduce viral shedding and the patient remained ill, demonstrating what the authors described as clinically significant resistance to peramivir. Next, doctors administered the only other available flu drug, zanamivir, for 10 days. The person then fully recovered.
"Additional, larger studies are needed to further refine our findings," says Dr Memoli. "But these cases of rapid appearance of drug-resistant 2009 H1N1 influenza in immune-compromised patients are worrisome and should prompt clinicians to reconsider how they use available flu drugs."
The mutation that allows the pandemic (H1N1) 2009 influenza virus to resist oseltamivir also significantly reduces the virus's susceptibility to peramivir. If a relatively short course of oseltamivir causes a mutant flu strain to emerge in a particular patient, that person may not respond to peramivir. Zanamivir might be a good choice if a patient does not respond within a few days to oseltamivir, Dr Memoli says. However, because zanamivir must be inhaled, patients who are very ill and whose breathing is mechanically supported cannot be given zanamivir.
"As clinicians, we should carefully consider our treatment options and use all the drugs available to us wisely. This is especially important in a patient with prolonged infection or when an antiviral drug fails to cure the patient after the recommended course of treatment," says Dr Memoli.
Previously it was reported that a kidney transplant patient in Western Australia developed resistance to oseltamivir and ultimately the patient's infection was cleared by zanamivir treatment (Medical Journal of Australia, 11 Jan 2010... http://www.mja.com.au/public/issues/192_03_010210/spe11148_fm.html
Although both oseltamivir and zanamivir are inhibitors of the activity of the influenza virus neuraminidase protein, the oseltamivir-resistance (His274Tyr) mutation does not confer resistance to zanamivir. The interesting feature of the NIAID report is the rapidity of appearance of oseltamivir resistance and the lack of response to another antiviral agent, now in experimental testing, intravenous peramivir, which presumably has the same site of action as oseltamivir.
One patient's infection was ultimately cleared by zanamivir treatment. It is not recorded if the patient's virus remained zanamivir sensitive. - Mod.CP]
Patricia A. Doyle DVM, PhD Bus Admin, Tropical Agricultural Economics Univ of West Indies Please visit my "Emerging Diseases" message board at:http://www.emergingdisease.org/phpbb/index.php Also my new website: http://drpdoyle.tripod.com/ Zhan le Devlesa tai sastimasa Go with God and in Good Health
All information posted on this web site is
the opinion of the author and is provided for educational purposes only.
It is not to be construed as medical advice. Only a licensed medical doctor
can legally offer medical advice in the United States. Consult the healer
of your choice for medical care and advice.